Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor

Citation
S. Petersenn et al., Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor, ENDOCRINOL, 142(6), 2001, pp. 2649-2659
Citations number
40
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
ENDOCRINOLOGY
ISSN journal
00137227 → ACNP
Volume
142
Issue
6
Year of publication
2001
Pages
2649 - 2659
Database
ISI
SICI code
0013-7227(200106)142:6<2649:GSATRO>2.0.ZU;2-2
Abstract
Synthetic GH secretagogues stimulate GH release through binding to a recent ly cloned specific GH secretagogue receptor (GHS-R). The endogenous ligand of this receptor may be part of a new endocrine pathway controlling GH secr etion. Two different receptor variants, type 1a and 1b, have been described that differ in their 3'-terminal amino acids. We investigated the genomic structure and transcriptional regulation of the human GHS-R. An 18-kb genom ic clone including sequences encoding for the two GHS-R variants was isolat ed. Sequencing revealed that the two variants originate from specific RNA p rocessing of a single gene that spans approximately 4.1 kb. The transcripti on start site was defined by 5'-inverse PCR analysis at position -227. RT-P CR analysis points to differential transcriptional initiation and processin g. Type la is encoded by two exons; 2152 bp of intronic sequence are remove d by splicing at position 796/797 relative to the translation start site. T ype Ib is encoded by a single exon. A putative polyadenylation signal conse nsus motif was identified at position +4118; 2.7 kb of the 5'-flanking regi on were sequenced, and putative transcription factor binding sites were ide ntified. Transcriptional regulation was investigated by transient transfect ions using promoter fragments ranging in size from 168-1745 bp; 1745 bp of the GHS-R promotor directed significant levels of luciferase expression in GH, rat pituitary cells, whereas no activity was detected in monkey kidney COS-7 cells, human endometrium Skut-1B cells, mouse hypothalamic LHRH neuro nal GT1-7 cells, or mouse corticotroph pituitary AtT20 cells. A minimal 309 -bp promoter allowed pituitary-specific expression. Its activity in COS-7 c ells was enhanced by cotransfection of the pituitary-specific transcription factor Pit-1. We did not find any regulation of the GHS-R promoter by fors kolin, somatostatin, insulin-like growth factor I, or 12-O-tetraphorbol 12- myristate 13-acetate. Thyroid hormone and estrogen lead to a significant st imulation; glucocorticoids lead to a significant inhibition. Further mappin g suggests a thyroid hormone-responsive element, an estrogen-responsive ele ment, and a glucocorticoid-responsive element located between -309 and the translation start codon. These studies demonstrate the nature of the human GHS-R gene and identify its 5'-flanking region. Furthermore, pituitary-spec ific activity of the promoter and regulation by various hormones are demons trated.